RaQualia Pharma Inc.TSE 4579

ラクオリア創薬株式会社 · Pharmaceutical · FY ends Dec

Share price at FY-end
¥1,010
FY ending Dec 2025
Market cap at FY-end
¥24.7B
Dividend per share
—
Avg. director pay
¥17.2M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 KOREA SECURITIES DEPOSITORY-SAMSUNG 2,594,100 10.61% ¥2.6B —
2 Yuichi Kakinuma 2,384,700 9.75% ¥2.4B —
3 ファイザー株式会社 743,000 3.04% ¥750M —
4 モルガン・スタンレーMUFG証券株式会社 294,807 1.21% ¥298M —
5 株式会社エス・ビー・シー 251,300 1.03% ¥254M —
6 株式会社アドバンスト・メディア 223,800 0.92% ¥226M —
7 Tokyo Tanshi Co., Ltd. 221,500 0.91% ¥224M —
8 田名後 貴裕 169,500 0.69% ¥171M —
9 香本 育良 157,000 0.64% ¥159M —
10 野村證券株式会社
Asset-management company of 野村 浩子
156,798 0.64% ¥158M —

Officers' holdings and pay

NameTitleSharesValuePay
須藤 正樹 Representative Director 30,232 ¥30.5M —
宇都 克裕 Director 19,739 ¥19.9M —
土屋 裕弘 Director — — —
石井 幸佑 Director — — —
Yuichi Kakinuma Director 2,384,700 ¥2.4B —
中野 貴之 Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 ¥1,010 ¥11.53 87.6x — 24,458,673
FY ending Dec 2024 ¥1,010 ¥-22.87 147.7x — 21,838,529
FY ending Dec 2023 ¥1,232 ¥-14.98 — — 21,623,281
FY ending Dec 2022 ¥1,232 ¥34.50 35.7x — 20,977,181
FY ending Dec 2021 ¥1,174 ¥36.07 32.5x — 20,955,142
FY ending Dec 2020 ¥1,174 ¥-28.97 — — 20,951,642
FY ending Dec 2019 ¥1,174 ¥0.26 5,157.7x — 20,950,142
FY ending Dec 2018 — ¥-54.23 — — 20,388,389
FY ending Dec 2017 — ¥-2.99 — — 20,295,236
FY ending Dec 2016 — ¥-38.80 — — 18,767,200
Source: annual securities reports on EDINET. Values are estimates. Methodology